Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma

NCT05025423 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class

Stopped The study sponsor withdrew funding early, forcing this study to stop all activity and close pre-maturely.

Conditions

Interventions

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators